Focusing on anti-beta-adrenergic receptor antibodies (anti-β-AR Ab), levels have been described as increased in patients with myocarditis and dilated cardiomyopathy (DCM) and are associated with heart failure and arrhythmogenic events (8–10). This evidence concerns the gene ADRB2 and heart failure.